Inputs: momentum, trendVelocity
Mixed signal: momentum 58/100, trend 54/100.
Prediction result · Ensemble engineUpdated 5:00 AM
ABTABT stock price outlook
$106.16+1.52% since prev closeBullish
ABT is up 1.52% since the previous close on the latest cached quote at $106.16. Mixed signal: momentum 58/100, trend 54/100.
Universal leanStock
ABT
ABT
$106.16+1.52%
LEANSOFT mild bid
WHY
- ABT is up 1.52% since the previous close on the latest cached quote at $106.16. Mixed signal: momentum 58/100, trend 54/100.
- Bull input: Sentiment 60/100 with price up 1.5% confirms catalyst follow-through.
RISK
Quote row is current from the latest cached feed.
INVALIDATE
Invalidate on a decisive break of the session bid, catalyst reversal, or model edge flipping bearish.
AI Signal
Bullish · Bullish setup
live data
Cached quote refreshed 2026-11-02T05:00:56.841Z. Change is measured since the previous close.
Quote source
Cron batch chart feed 2026-11-02T05:00:56.841Z
Move since previous close
+1.52%
News Sentiment60/100
Price Momentum58/100
Trend Velocity54/100
Volatility Risk46/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on ABT
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgePlayableNeutral
Inputs: newsSentiment, dayChange
Sentiment 60/100 with price up 1.5% confirms catalyst follow-through.
Inputs: unusualVolume, dayChange
Volume read 45/100 with price drift 1.5% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 46/100 is mid-range — no edge.
Inputs: pctOfRange, trendVelocity
Mid-range positioning — no edge from range alone.
Inputs: newsSentiment, weekChange
Sentiment 60/100 vs week change 1.2% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 0.0% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 56 — healthy uptrend region.
Inputs: momentum, dayChange, vsSma50
Momentum 58/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 60/100 and weekly change 1.2% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 45/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 46/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 59% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 60/100 and momentum 58/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
50d SMA distance 0.0% is not decisive.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 56 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 58/100, trend 54/100.
- Price within 0.0% of the 50d SMA — no clear structural read.
- Momentum 58/100 is not strong enough to confirm a breakout.
Counter-trees
- Sentiment 60/100 with price up 1.5% confirms catalyst follow-through.
- Oscillator at 56 — healthy uptrend region.
Bull Case
- Sentiment 60/100 with price up 1.5% confirms catalyst follow-through.
- Oscillator at 56 — healthy uptrend region.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Yahoo Finance57
Is Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now? - Yahoo Finance
10/27/2026, 12:00:02 PM
Seeking Alpha69
Abbott Laboratories: A New Growth Story Takes Shape (NYSE:ABT) - Seeking Alpha
10/26/2026, 11:50:13 AM
Barron's55
ABT | Abenojar Inversiones S.A. Stock Overview (U.K.: London) - Barron's
10/28/2026, 1:33:09 PM
Key stats
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Market cap
- $183.77B
- 52-week range
- $132.025/$81.97
- Volume
- 8,440,815
- Avg volume
- 5,447,818
- Analyst 1-yr target
- $120.00
- Exchange
- NYSE
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Not yet scheduled
Estimate
N/A
Actual
$1.42
- • Last report Oct 21, 2026 (Sep 2026): EPS $1.42 vs $1.43 expected, -0.7% surprise.
- • Beat estimates in 2 of the last 4 quarters.
Risk Warnings
- • Quote row is current from the latest cached feed.
- • Quotes can be delayed. Research only, not investment advice.
ABT questions
What is the MarketPicks AI signal for ABT stock (ABT)?
As of Nov 2, 12:00 AM ET, the ensemble reads bullish on ABT — bullish — 2 of 16 bots up, with 2 bull, 0 bear and 14 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest ABT price on MarketPicks?
ABT was $106.16 on the latest quote (Nov 2, 12:00 AM ET), +1.52% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for ABT mean?
Scores run from 0 to 100, with 50 neutral. ABT shows momentum 58/100, trend velocity 54/100 and volatility risk 46/100, with news sentiment at 60/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.